A carregar...

Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells

Despite recent advances in the clinical evaluation of various poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer (TNBC) patients, data defining potential anti-tumor mechanisms beyond PARP inhibition for these agents are lacking. To address this issue, we investigated the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Chuang, Hsiao-Ching, Kapuriya, Naval, Kulp, Samuel K., Chen, Ching-Shih, Shapiro, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297209/
https://ncbi.nlm.nih.gov/pubmed/22678161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2106-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!